Events

Clinical execution and pharmacovigilance are often managed in parallel rather than in partnership. For sponsors, that disconnect can create avoidable delays, inconsistent safety decision-making, protocol amendments, and added pressure on sites and study teams. In early-phase and complex trials, where risk profiles are still emerging, these gaps can have a direct impact on both patient...

Cleanroom ISO classification is a foundational decision that directly impacts facility design, GMP manufacturing operations, and regulatory outcomes in biotech and pharmaceutical environments. This is especially critical in cell and gene therapy, viral vector, API, mRNA, and sterile ATMP manufacturing, where product protection, biohazard containment, and operator safety must be carefully balanced. In this webinar,...

We are very excited to announce our outdoor Biotech Community Event at the Biovista Life Science Campus. Mark your calendars for a great opportunity to connect with industry leaders, explore innovative products, and mingle with fellow professionals in the biotech community. ✨ What to Expect: Vendor Exhibits: Discover a diverse range of exhibitors showcasing cutting-edge...

This sponsor-led webinar will explore the real-world impact of using a centralized trial services platform through firsthand experiences from both Cogent and Helus Pharma. Discover how working with a single partner to manage patient logistics, site payments, and financial coordination influenced day-to-day trial operations, communication across stakeholders, and the overall experience for sites and participants....

As demand for advanced therapies continues to surge, the biopharma industry is under pressure to innovate faster in high-risk areas like drug discovery and cell therapy. These fields face persistent challenges, such as high costs, long development timelines, and complex regulatory landscapes. To that end, MaxCyte has introduced a new high-throughput electroporation platform that streamlines...

Antibody-drug conjugates (ADCs) present unique analytical challenges, particularly in maintaining consistent drug-to-antibody ratio (DAR), minimizing variability, and reducing reliance on time-intensive off-line methods. These challenges are further compounded by the need to limit handling of highly potent payloads while maintaining process control. This webinar explores how variable pathlength spectroscopy enables rapid, accurate at-line and in-line...

Bringing innovative antibody therapeutics to market quickly requires more than upstream efficiency. It demands adaptable and robust downstream purification strategies. As novel mAb formats increase in complexity, purification challenges grow. Achieving required purity and yield often extends beyond traditional 2–3 step platform processes, requiring expanded chromatography options and optimized buffer systems. In this webinar, we...